Delpha Capital Management’s Merck MRK Stock Holding History

Delpha Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,942	Closed	-$158K	–	800
2017 Q4	$158K	Buy	+2,942	New	+$163K	0.17%	73

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Delpha Capital Management's MRK Position: Q1 2018 in Review

Delpha Capital Management sold out of Merck (MRK) in Q1 2018, closing a stake of 2,942 shares — an estimated $158K sold.

Delpha Capital Management first reported a position in MRK in Q4 2017 and held it in 1 quarter. The position peaked at $158K in Q4 2017. 1,993 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

Delpha Capital Management reported no remaining Merck position as of Q1 2018 after selling out during the quarter.
Delpha Capital Management sold 2,942 Merck shares in Q1 2018, an estimated $158K.
Delpha Capital Management first reported a position in Merck in Q4 2017 and held it in 1 quarter.
Delpha Capital Management's Merck position peaked at $158K in Q4 2017.
1,993 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.